Stocksigma LogoStocksigma Logo

Caplin Point Reports Strong Q2 FY27 With Solid Revenue and PAT Growth

Caplin Point Laboratories reported consolidated Q2 FY27 revenue from operations of ₹629.84 Cr, up 17.9% YoY (3.2% QoQ), while net profit grew 13.8% YoY to

Caplin Point Reports Strong Q2 FY27 With Solid Revenue and PAT Growth

Caplin Point Laboratories Ltd · Investor Presentation · 12 Nov 2026, 6:51 pm

Caplin Point Reports Strong Q2 FY27 With Solid Revenue and PAT Growth Caplin Point Laboratories reported consolidated Q2 FY27 revenue from operations of ₹629.84 Cr, up 17.9% YoY (3.2% QoQ), while net profit grew 13.8% YoY to ₹182.35 Cr with a 27.5% PAT margin. EBITDA stood at ₹256.51 Cr, up 16.8% YoY with margins at 38.7%. For H1 FY27, revenue reached ₹1,240.20 Cr (+18.8% YoY) and PAT reached ₹361.42 Cr (+16.2% YoY). The balance sheet remains debt-free with free cash reserves of ₹1,534 Cr, funding an ongoing ₹1,000+ Cr capex plan entirely through internal accruals.

Original exchange filing (PDF)

More announcements from Caplin Point Laboratories Ltd

All Caplin Point Laboratories Ltd announcements